These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9397073)

  • 1. Dwindling supplies of anti-D.
    Beveridge HE
    Med J Aust; 1997 Nov; 167(9):509-10. PubMed ID: 9397073
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical significance of anti-G in alloimmunized pregnant women.
    Hadley A; Poole J; Poole G
    Transfusion; 1997 Sep; 37(9):985. PubMed ID: 9308650
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Harding K
    Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
    [No Abstract]   [Full Text] [Related]  

  • 4. Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy.
    Elasoud K; McClure G; Halliday HL; Dornan JC
    Ulster Med J; 1997 May; 66(1):62-4. PubMed ID: 9185494
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of immunoprophylaxis with anti-D immunoglobin.
    Engelfriet CP; Reesink HW; Judd WJ; Ulander VM; Kuosmanen M; Koskinen S; Rouger P; Morelati F; Tantalo V; Fujii T; de Haas M; van der Schoot CE; Overbeeke M; Koelewijn J; Bonsel G; Vrijkotte T; Zupańska B; Martin-Vega C; Parra Lopez R; de Silva M; Contreras M; Panzer S; Ulm B; Mayr WR
    Vox Sang; 2003 Nov; 85(4):328-37. PubMed ID: 14633261
    [No Abstract]   [Full Text] [Related]  

  • 6. Rescue in inner space: management of Rh hemolytic disease.
    Liley HG
    J Pediatr; 1997 Sep; 131(3):340-2. PubMed ID: 9329405
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and treatment of severe alloimmunization.
    Bennebroek Gravenhorst J
    Vox Sang; 1994; 67 Suppl 3():235-8. PubMed ID: 7975499
    [No Abstract]   [Full Text] [Related]  

  • 8. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.
    Pegoraro V; Urbinati D; Visser GHA; Di Renzo GC; Zipursky A; Stotler BA; Spitalnik SL
    PLoS One; 2020; 15(7):e0235807. PubMed ID: 32687543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 11. The continuing struggle to eliminate hemolytic disease of the newborn from RH (D).
    Barlow JF
    S D J Med; 1999 Jan; 52(1):7-8. PubMed ID: 9926725
    [No Abstract]   [Full Text] [Related]  

  • 12. The history of rhesus prophylaxis with anti-D.
    Wegmann A; Glück R
    Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 14. Management and prevention of red cell alloimmunization in pregnancy: a systematic review.
    Moise KJ; Argoti PS
    Obstet Gynecol; 2012 Nov; 120(5):1132-9. PubMed ID: 23090532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The global burden of Rh disease.
    Zipursky A; Paul VK
    Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F84-5. PubMed ID: 21037283
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevention and management of haemolytic disease of the newborn.
    Contreras M; de Silva M
    J R Soc Med; 1994 May; 87(5):256-8. PubMed ID: 8207718
    [No Abstract]   [Full Text] [Related]  

  • 18. [The expediency of producing antirhesus-Rh0(D) immunoglobulin and its use for preventing hemolytic disease of the newborn (for discussion)].
    Mikhaĭlova AA; Klimova NIa
    Gematol Transfuziol; 1992; 37(7-8):39-40. PubMed ID: 1342987
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
    Jedwabny A; Suchocki S; Bobrowska G
    Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
    [No Abstract]   [Full Text] [Related]  

  • 20. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.